Detalhe da pesquisa
1.
The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers.
BJU Int
; 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38839570
2.
Enhanced clinical decisions for management of benign prostatic hyperplasia using patient-reported outcomes: protocol for a prospective observational study.
BMC Urol
; 24(1): 110, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38773430
3.
How I do it: Aquablation in very large prostates (> 150 mL).
Can J Urol
; 29(2): 11111-11115, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35429430
4.
Men with lower urinary tract symptoms secondary to BPH undergoing Aquablation with very large prostates (> 150 mL).
Can J Urol
; 28(6): 10884-10888, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34895392
5.
A New Brief Clinical Assessment of Lower Urinary Tract Symptoms for Women and Men: LURN SI-10.
J Urol
; 203(1): 164-170, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31364922
6.
Patient demographic and psychosocial characteristics associated with 30-day recall of self-reported lower urinary tract symptoms.
Neurourol Urodyn
; 39(7): 1939-1948, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32856723
7.
Can 7 or 30-Day Recall Questions Capture Self-Reported Lower Urinary Tract Symptoms Accurately?
J Urol
; 202(4): 770-778, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31039099
8.
A new outcome measure for LUTS: Symptoms of Lower Urinary Tract Dysfunction Research Network Symptom Index-29 (LURN SI-29) questionnaire.
Neurourol Urodyn
; 38(6): 1751-1759, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31225927
9.
Prevalence and Characteristics of Urinary Incontinence in a Treatment Seeking Male Prospective Cohort: Results from the LURN Study.
J Urol
; 200(2): 397-404, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29477718
10.
Regulation of Latent Membrane Protein 1 Signaling through Interaction with Cytoskeletal Proteins.
J Virol
; 89(14): 7277-90, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25948738
11.
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia using Patient-Reported Outcomes: Protocol for a Prospective Observational Study.
Res Sq
; 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38766034
12.
Identification of transmembrane protein 134 as a novel LMP1-binding protein by using bimolecular fluorescence complementation and an enhanced retroviral mutagen.
J Virol
; 86(20): 11345-55, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22855487
13.
The 10-item LURN Symptom Index (LURN SI-10) Detects Additional Symptoms and Shows Convergent Validity With the IPSS in Men Presenting With Lower Urinary Tract Symptoms.
Urology
; 171: 184-189, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36370771
14.
The 17-gene Genomic Prostate Score assay as a predictor of biochemical recurrence in men with intermediate and high-risk prostate cancer.
PLoS One
; 17(9): e0273782, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36048818
15.
TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease.
Nat Commun
; 13(1): 2133, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35440548
16.
Characterization of the latent membrane protein 1 signaling complex of Epstein-Barr virus in the membrane of mammalian cells with bimolecular fluorescence complementation.
Virol J
; 8: 414, 2011 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21864338
17.
The Distribution of Post-Void Residual Volumes in People Seeking Care in the Symptoms of Lower Urinary Tract Dysfunction Network Observational Cohort Study With Comparison to Asymptomatic Populations.
Urology
; 130: 22-28, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31018115